Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health Network	STROKE	2024
Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	JOURNAL OF CLINICAL MEDICINE	2024
Endotoxemia and Platelets: 2 Players of Intrahepatic Microthrombosis in NAFLD	JACC. BASIC TO TRANSLATIONAL SCIENCE	2024
Prediction of new-onset atrial fibrillation with the C2HEST score in patients admitted with community-acquired pneumonia	INFECTION	2024
Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease	CARDIOVASCULAR DIABETOLOGY	2024
Risk of adverse events in anticoagulated patients with atrial fibrillation and non-alcoholic fatty liver disease	THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM	2024
Midregional‐proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta‐analysis	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION	2024
Acute upper and lower gastrointestinal bleeding management in older people taking or not taking anticoagulants: a literature review	FRONTIERS IN MEDICINE	2024
Incidence of All-Cause, Cardiovascular, and Atrial Fibrillation-Related Hospitalizations	JACC. ADVANCES	2024
Usefulness of the C2HEST score to predict new onset atrial fibrillation. A systematic review and meta‐analysis on >11 million subjects	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION	2024
Long-term risk of hospitalization and death in patients with mechanical prosthetic heart valves	THE AMERICAN JOURNAL OF CARDIOLOGY	2024
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study	BLOOD ADVANCES	2024
Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management: a case report	EUROPEAN HEART JOURNAL. CASE REPORTS	2023
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION	2023
A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists	JOURNAL OF CLINICAL MEDICINE	2023
Relationship between non-invasively detected liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI	CLINICAL RESEARCH IN CARDIOLOGY	2023
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
An international multidisciplinary consensus statement on MAFLD and the risk of CVD	HEPATOLOGY INTERNATIONAL	2023
Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C2HEST and mC2HEST scores: A report from the multicenter REALE-ACS registry	INTERNATIONAL JOURNAL OF CARDIOLOGY	2023

1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.